FRUSCIO ROBERT

Alviano, A., Pagni, F., Seminati, D., Casati, G., Jaconi, M., Fruscio, R., et al. (2026). Validation of QuANTUM-derived tumor cell fraction for molecular testing in high-grade serous tubo-ovarian carcinoma. NPJ PRECISION ONCOLOGY [10.1038/s41698-026-01414-0]. Dettaglio

Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Dettaglio

Capellini, E., Perotti, L., Guffanti, F., De Simone, G., Morabito, A., Ronchi, A., et al. (2026). Intermittent fasting enhances cisplatin-metformin efficacy in therapy-resistant ovarian cancer PDXs. ISCIENCE, 29(1) [10.1016/j.isci.2025.114300]. Dettaglio

Toss, A., Blondeaux, E., Tenedini, E., Bonamici, L., Graffeo, R., Livraghi, L., et al. (2026). Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study. ANNALS OF ONCOLOGY, 37(3), 364-377 [10.1016/j.annonc.2025.11.004]. Dettaglio

Leone Roberti Maggiore, U., Fanfani, F., Capasso, I., Perrone, E., Parisi, G., Zannoni, G., et al. (2026). Fertility-sparing vs hysterectomy for uterine STUMP: A pragmatic clinical study. EUROPEAN JOURNAL OF CANCER, 236(March 11, 2026) [10.1016/j.ejca.2026.116260]. Dettaglio